Development
Treatment.com AI Inc.
TREIF
$0.3496
-$0.0034-0.96%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 2.60K | 1.40K | 7.60K | 6.00K | 171.80K |
| Gross Profit | -2.60K | -1.40K | -7.60K | -6.00K | -171.80K |
| SG&A Expenses | 197.70K | 232.20K | 592.10K | 222.00K | 248.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 200.30K | 233.50K | 608.50K | 267.60K | 521.00K |
| Operating Income | -200.30K | -233.50K | -608.50K | -267.60K | -521.00K |
| Income Before Tax | -214.40K | -247.50K | -639.00K | -282.50K | -529.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -214.40K | -247.50K | -639.00K | -282.50K | -529.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -214.40K | -247.50K | -639.00K | -282.50K | -529.60K |
| EBIT | -200.30K | -233.50K | -608.50K | -267.60K | -521.00K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.03 | -0.04 | -0.10 | -0.04 | -0.08 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.06 | -0.03 | -0.05 |
| EPS Diluted | -0.03 | -0.04 | -0.10 | -0.04 | -0.08 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.06 | -0.03 | -0.05 |
| Average Basic Shares Outstanding | 6.63M | 6.63M | 6.62M | 6.62M | 6.62M |
| Average Diluted Shares Outstanding | 6.63M | 6.63M | 6.62M | 6.62M | 6.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |